id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1998-E-0073-0005,FDA,FDA-1998-E-0073,Determination of Regulatory Review Period for Purposes of Patent Extension; Vitreon,Notice,General Notice,1998-12-21T05:00:00Z,1998,12,1998-12-21T05:00:00Z,1999-07-16T03:59:59Z,2025-03-05T18:10:58Z,98-33457,0,0,0900006480583e30
FDA-1998-E-0073-0003,FDA,FDA-1998-E-0073,Letter from FDA Office of Health Affairs to the Honorable Bruce Lehman,Other,Letter(s),1998-12-15T05:00:00Z,1998,12,,,2025-03-05T17:58:55Z,,0,0,0900006480583e2c
FDA-1998-E-0073-0004,FDA,FDA-1998-E-0073,Letter from FDA Office of Health Affairs to the Honorable Bruce Lehman,Other,Letter(s),1998-12-15T05:00:00Z,1998,12,,,2025-03-05T18:00:43Z,,0,0,0900006480583e2f
FDA-1998-N-0026-0001,FDA,FDA-1998-N-0026,FDA,Notice,"NRD-Notice of Requesting Data, Info, & Views",1998-12-15T05:00:00Z,1998,12,,,2008-05-16T21:28:54Z,,0,0,09000064805648ac
FDA-1984-G-0001-0001,FDA,FDA-1984-G-0001,American Feed Industry Association; Withdrawal of Generally Recognized As Safe (GRAS) Petition - Notice of Withdrawl,Notice,NWL-Notice of Withdrawl,1998-12-09T05:00:00Z,1998,12,,,2014-07-17T17:24:14Z,,0,0,09000064805a7533
FDA-1998-P-0084-0002,FDA,FDA-1998-P-0084,"Citizen Petition Approval from FDA CDER to AndrxPharmaceuticals, Inc.",Other,Approval,1998-12-09T05:00:00Z,1998,12,,,2024-07-17T16:02:24Z,,0,0,0900006480584d84
FDA-1997-C-0043-0001,FDA,FDA-1997-C-0043,Closure Medical Corp.; Withdrawal of Color Additive Petition,Notice,Withdrawal,1998-12-07T05:00:00Z,1998,12,,,2024-11-06T13:59:15Z,,0,0,09000064805cfc65
FDA-1995-S-0039-0058,FDA,FDA-1995-S-0039,Report from FDA/CFSAN,Other,RPT-Report,1998-11-28T05:00:00Z,1998,11,2008-10-06T04:00:00Z,,2016-09-30T14:22:28Z,,0,0,090000648055c389
FDA-1998-N-0008-0001,FDA,FDA-1998-N-0008,Bioavailability and Bioequivalence Requirements; Abbreviated Applications; Proposed Revisions,Proposed Rule,Notice of Proposed Rulemaking (NPRM),1998-11-24T05:00:00Z,1998,11,1998-11-19T05:00:00Z,1999-02-03T04:59:59Z,2024-08-28T13:48:58Z,98-30880,0,0,0900006480558d83
FDA-1998-N-0006-0005,FDA,FDA-1998-N-0006,HF-7,Notice,NFR-Notice of Final Rule,1998-11-19T05:00:00Z,1998,11,,,2008-05-16T21:28:34Z,,0,0,0900006480558a70
FDA-1998-D-0097-0001,FDA,FDA-1998-D-0097,"Guidance for Industry on Fast Track Drug Development Programs: Designation, Development, and Application Review; Availability; Collection of Information",Notice,NAD-Notice of Availability of Data,1998-11-19T05:00:00Z,1998,11,1998-11-19T05:00:00Z,1999-02-17T04:59:59Z,2008-11-19T00:03:09Z,,0,0,0900006480586ae6
FDA-1998-N-0049-0001,FDA,FDA-1998-N-0049,Medical Devices; Revocation of Exemptions from Premarket Notification for Certain Cardiovascular and Physical Medicine Devices,Notice,Withdrawal,1998-11-19T05:00:00Z,1998,11,1998-11-19T05:00:00Z,1999-01-27T04:59:59Z,2026-01-23T22:34:42Z,,0,0,090000648056e79c
FDA-1996-N-0018-0001,FDA,FDA-1996-N-0018,Agency Information Collection Activities; Proposed Collection; MedWatch: The FDA Medical Products Reporting Program; Comment Request A.G,Notice,General Notice,1998-11-13T05:00:00Z,1998,11,1998-11-13T05:00:00Z,1999-01-12T04:59:59Z,2024-09-12T15:07:50Z,,0,0,09000064804fa4f3
FDA-1998-D-0002-0001,FDA,FDA-1998-D-0002,FDA,Notice,NAD-Notice of Availability of Data,1998-11-06T05:00:00Z,1998,11,1998-11-06T05:00:00Z,1999-02-04T04:59:59Z,2008-05-16T21:17:54Z,,0,0,0900006480558677
FDA-1998-E-0073-0002,FDA,FDA-1998-E-0073,Letter from FDA Office of Health Affairs to U.S. Patent and Trademark Office,Other,Letter(s),1998-11-06T05:00:00Z,1998,11,,,2025-03-05T17:50:58Z,,0,0,0900006480583e2a
FDA-1998-D-0039-0003,FDA,FDA-1998-D-0039,FDA,Notice,NAD-Notice of Availability of Data,1998-11-06T05:00:00Z,1998,11,,,2008-05-16T21:23:02Z,,0,0,090000648056e4fd
FDA-1998-N-0027-0001,FDA,FDA-1998-N-0027,Electronic Reporting of Postmarketing Adverse Drug Reactions; Request for Comments,Notice,Proposed Guidelines,1998-11-06T05:00:00Z,1998,11,1998-11-05T05:00:00Z,1999-02-04T04:59:59Z,2024-11-18T16:45:45Z,98-29564,0,0,0900006480564ac8
FDA-1998-E-0073-0001,FDA,FDA-1998-E-0073,Letter from FDA Office of Health Affairs to U.S. Patent and Trademark Office,Other,Letter(s),1998-11-06T05:00:00Z,1998,11,,,2025-03-05T17:49:53Z,,0,0,0900006480583dc4
FDA-1976-N-0520-0011,FDA,FDA-1976-N-0520,Eli Lilly & Co. and Bristol-Myers Squibb Co.; Withdrawal of Approval of Three New Drug Applications for Estrogen-Androgen Combination Drugs,Notice,NWL-Notice of Withdrawl,1998-11-04T05:00:00Z,1998,11,,,2018-08-02T16:31:49Z,,0,0,090000648053be5b
FDA-1976-N-0520-0010,FDA,FDA-1976-N-0520,"Eli Lilly & Co. and Bristol-Myers Squibb Co.; Withdrawal of Approval of
Three New Drug Applications for Estrogen-Androgen Combination Drugs",Notice,Withdrawal,1998-11-04T05:00:00Z,1998,11,,,2018-08-02T16:31:12Z,98-29049,0,0,090000648053be5a
FDA-1978-N-0018-0431,FDA,FDA-1978-N-0018,Sunscreen Drug Products for Over-the-Counter Human Use; Amendment to the Tentative Final Monograph; Enforcement Policy,Proposed Rule,Notice of Proposed Rulemaking (NPRM),1998-11-02T05:00:00Z,1998,11,1998-11-02T05:00:00Z,1999-01-21T04:59:59Z,2019-07-24T18:18:58Z,98-28274,0,0,090000648055a643
FDA-1997-D-0009-0002,FDA,FDA-1997-D-0009,FDA,Notice,NAD-Notice of Availability of Data,1998-10-21T04:00:00Z,1998,10,,,2008-05-16T21:59:17Z,,0,0,09000064805c9a37
FDA-1998-D-0021-0001,FDA,FDA-1998-D-0021,FDA,Notice,NEC-Notice of Extension,1998-10-20T04:00:00Z,1998,10,1998-10-20T04:00:00Z,1998-11-24T04:59:59Z,2008-05-16T21:18:01Z,,0,0,0900006480564036
FDA-1998-N-0068-0005,FDA,FDA-1998-N-0068,HFM-17,Notice,NEC-Notice of Extension,1998-10-20T04:00:00Z,1998,10,1998-10-20T04:00:00Z,1998-11-17T04:59:59Z,2008-05-16T21:31:26Z,,0,0,0900006480571d21
FDA-1998-D-0035-0001,FDA,FDA-1998-D-0035,FDA,Notice,NAD-Notice of Availability of Data,1998-10-20T04:00:00Z,1998,10,1998-10-20T04:00:00Z,1998-12-15T04:59:59Z,2008-05-16T21:18:11Z,,0,0,09000064805657a0
FDA-1998-N-0068-0004,FDA,FDA-1998-N-0068,HFM-17,Notice,NEC-Notice of Extension,1998-10-20T04:00:00Z,1998,10,1998-10-20T04:00:00Z,1998-11-17T04:59:59Z,2008-05-16T21:31:25Z,,0,0,0900006480571d20
FDA-1998-N-0070-0001,FDA,FDA-1998-N-0070,"Privacy Act of 1974; Altered System of Records, Including Addition of Routine Use(s) to an Existing System of Records",Notice,Privacy Act,1998-10-20T04:00:00Z,1998,10,1998-10-19T04:00:00Z,1998-11-19T04:59:59Z,2024-09-30T18:10:52Z,98–27937,0,0,0900006480571de0
FDA-1998-N-0068-0006,FDA,FDA-1998-N-0068,HFM-17,Notice,NEC-Notice of Extension,1998-10-20T04:00:00Z,1998,10,1998-10-20T04:00:00Z,1998-11-17T04:59:59Z,2008-05-16T21:31:25Z,,0,0,0900006480571d22
FDA-1998-N-0107-0002,FDA,FDA-1998-N-0107,Medical Devices; 30-Day Notices and 135-Day PMA Supplement Review,Notice,Notice of Final Rule,1998-10-09T04:00:00Z,1998,10,,,2024-08-21T14:50:19Z,,0,0,0900006480587ef2
FDA-1998-N-0053-0001,FDA,FDA-1998-N-0053,FDA,Notice,NPR-Notice of Proposed Rule-Making,1998-10-09T04:00:00Z,1998,10,1998-10-09T04:00:00Z,1998-11-24T04:59:59Z,2008-05-16T21:29:13Z,,0,0,090000648056ea01
FDA-1993-C-0016-0002,FDA,FDA-1993-C-0016,Listing of Color Additives Exempt from Certification; Canthaxanthin; Confirmation of Effective Date; Correction,Notice,Notice of Confirmation of Effective Date,1998-10-02T04:00:00Z,1998,10,,,2024-04-25T17:43:21Z,98-25640,0,0,09000064804fa730
FDA-1984-D-0009-0001,FDA,FDA-1984-D-0009,FDA,Notice,N-Notice,1998-09-28T04:00:00Z,1998,9,,,2008-05-30T22:53:25Z,,0,0,09000064805a77e7
FDA-1998-N-0006-0004,FDA,FDA-1998-N-0006,HF-27,Notice,NCR-Notice of Correction,1998-09-24T04:00:00Z,1998,9,,,2008-05-16T21:28:34Z,,0,0,0900006480558a6f
FDA-1998-N-0006-0003,FDA,FDA-1998-N-0006,HF-7,Notice,NWL-Notice of Withdrawl,1998-09-24T04:00:00Z,1998,9,,,2008-05-16T21:28:34Z,,0,0,0900006480558a6e
FDA-1998-D-0100-0001,FDA,FDA-1998-D-0100,FDA,Notice,NAD-Notice of Availability of Data,1998-09-24T04:00:00Z,1998,9,1998-09-24T04:00:00Z,1998-11-24T04:59:59Z,2008-05-16T21:23:21Z,,0,0,090000648058708a
FDA-1998-D-0102-0003,FDA,FDA-1998-D-0102,FDA,Notice,NCR-Notice of Correction,1998-09-14T04:00:00Z,1998,9,,,2008-05-16T21:23:24Z,,0,0,090000648058738c
FDA-1981-N-0043-0006,FDA,FDA-1981-N-0043,Pediculicide Drug Products for Over-the-Counter Human Use; Final Monograph; Technical Amendment; Correction,Notice,Correction,1998-09-09T04:00:00Z,1998,9,,,2021-03-15T13:27:27Z,98-23400,0,0,09000064805af2f7
FDA-1998-N-0041-0003,FDA,FDA-1998-N-0041,Biological Products Regulated Under Section 351 of the Public Health Services Act; implementation of Biologics License; Elimination of Establishment License and Product License; Correction,Notice,Correction,1998-09-04T04:00:00Z,1998,9,,,2026-01-30T03:45:33Z,98-23586,0,0,090000648056e5a6
FDA-1992-P-0047-0001,FDA,FDA-1992-P-0047,Denial Letter from FDA CDRH to Hyman Phelps & McNamara P.C.,Other,Denial of Petition,1998-09-02T04:00:00Z,1998,9,,,2024-11-07T18:49:27Z,,0,0,090000648052bc92
FDA-1995-C-0050-0002,FDA,FDA-1995-C-0050,Listing of Color Additives for Coloring Sutures; D&C Violet No. 2; Confirmation of Effective Date,Rule,Confirmation of Effective Date,1998-09-01T04:00:00Z,1998,9,1998-08-28T04:00:00Z,,2017-06-13T18:13:58Z,98-23106,0,0,0900006480561d8f
FDA-1980-N-0074-0064,FDA,FDA-1980-N-0074,HFA-305 to Kleinfeld Kaplan & Becker,Other,ACK-Acknowledgement Letter,1998-08-27T04:00:00Z,1998,8,,,2008-05-30T22:52:38Z,,0,0,09000064805bb491
FDA-1998-D-0052-0002,FDA,FDA-1998-D-0052,FDA,Notice,NEC-Notice of Extension,1998-08-27T04:00:00Z,1998,8,1998-08-27T04:00:00Z,1998-11-25T04:59:59Z,2008-05-16T21:23:07Z,,0,0,090000648056e979
FDA-1998-N-0029-0001,FDA,FDA-1998-N-0029,Medical Device Warning Letter Pilot Termination,Notice,General Notice,1998-08-27T04:00:00Z,1998,8,,,2024-11-14T20:53:05Z,03-3436,0,0,0900006480564dae
FDA-1998-N-0071-0002,FDA,FDA-1998-N-0071,Regulations on Statements made for Dietary Supplements Concerning the Effects of the Products on the Structure or Function of the Body; Extension of Comment Period,Notice,NEC-Notice of Extension,1998-08-27T04:00:00Z,1998,8,1998-08-27T04:00:00Z,1998-09-29T03:59:59Z,2008-07-23T23:37:30Z,,0,0,09000064805730ad
FDA-1998-N-0103-0003,FDA,FDA-1998-N-0103,FDA,Notice,NM-Notice of Meeting,1998-08-20T04:00:00Z,1998,8,,,2008-05-16T21:37:58Z,,0,0,090000648058750a
FDA-1998-N-0103-0004,FDA,FDA-1998-N-0103,FDA,Notice,NM-Notice of Meeting,1998-08-20T04:00:00Z,1998,8,,,2008-05-16T21:37:58Z,,0,0,090000648058750c
FDA-1998-N-0041-0002,FDA,FDA-1998-N-0041,Biological Products Regulated Under Section 351 of the Public Health Services Act; implementation of Biologics License; Elimination of Establishment License and Product License; Public Workshop,Notice,Public Meetings,1998-08-19T04:00:00Z,1998,8,1998-08-19T04:00:00Z,1998-10-15T03:59:59Z,2026-01-30T03:45:58Z,98-21406,0,0,090000648056e59a
FDA-1998-V-0065-0003,FDA,FDA-1998-V-0065,Acknowledgement Letter to Universal Studios Florida,Other,Acknowledgement Letter/Receipt,1998-08-18T04:00:00Z,1998,8,,,2012-01-26T02:41:16Z,,0,0,0900006480571c7d
FDA-1981-N-0043-0005,FDA,FDA-1981-N-0043,Pediculicide Drug Products for Over-the-Counter Human Use; Final Monograph; Technical Amendment,Notice,Notice of Final Rule,1998-08-14T04:00:00Z,1998,8,,,2021-03-15T13:13:26Z,98-21794,0,0,09000064805af2f6
FDA-1998-P-0016-0001,FDA,FDA-1998-P-0016,Acknowledgement Letter to Kenneth B. Lerman,Other,ACK-Acknowledgement Letter,1998-08-14T04:00:00Z,1998,8,,,2008-10-09T19:30:14Z,,0,0,09000064805639e6
FDA-1998-N-0068-0003,FDA,FDA-1998-N-0068,FDA,Notice,NEC-Notice of Extension,1998-08-03T04:00:00Z,1998,8,1998-08-03T04:00:00Z,1998-10-16T03:59:59Z,2008-05-16T21:31:26Z,,0,0,0900006480571d19
FDA-1998-N-0068-0002,FDA,FDA-1998-N-0068,FDA,Notice,NEC-Notice of Extension,1998-08-03T04:00:00Z,1998,8,1998-08-03T04:00:00Z,1998-10-16T03:59:59Z,2008-05-16T21:31:26Z,,0,0,0900006480571d18
FDA-1998-N-0041-0001,FDA,FDA-1998-N-0041,Biological Products Regulated Under Section 351 of the Public Health Services Act; implementation of Biologics License; Elimination of Establishment License and Product License,Notice,Proposed Guidelines,1998-08-03T04:00:00Z,1998,8,1998-08-03T04:00:00Z,1998-10-15T03:59:59Z,2026-01-30T03:46:21Z,98-20427,0,0,090000648056e598
FDA-1976-N-0027-0005,FDA,FDA-1976-N-0027,"Notice of Final Rule re Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products for Over-the- Counter Human Use; Amendment of Monograph for OTC Nasal Decongestant Drug
Products",Notice,Notice of Final Rule,1998-07-31T04:00:00Z,1998,7,,,2015-10-29T19:26:46Z,,0,0,090000648051b690
FDA-1997-N-0069-0002,FDA,FDA-1997-N-0069,FDA,Notice,NWL-Notice of Withdrawl,1998-07-31T04:00:00Z,1998,7,,,2008-05-16T22:01:20Z,,0,0,09000064805d054a
FDA-1998-N-0103-0002,FDA,FDA-1998-N-0103,FDA,Notice,N-Notice,1998-07-31T04:00:00Z,1998,7,,,2008-05-16T21:37:59Z,,0,0,0900006480587503
FDA-1998-N-0103-0001,FDA,FDA-1998-N-0103,FDA,Notice,NM-Notice of Meeting,1998-07-31T04:00:00Z,1998,7,1998-07-31T04:00:00Z,1998-09-12T03:59:59Z,2008-05-16T21:37:58Z,,0,0,090000648058749a
FDA-1997-N-0010-0002,FDA,FDA-1997-N-0010,Hematopoietic Stem/Progenitor Cell Products: Discussion of Unrelated AflogeneicPlacental/Umbilical Cord Blood and Peripheral Blood Cell Banking and Transplantation; Notice of Public Workshop,Notice,NM-Notice of Meeting,1998-07-31T04:00:00Z,1998,7,,,2008-11-26T03:37:19Z,,0,0,09000064805c9a4f
FDA-1980-N-0074-0063,FDA,FDA-1980-N-0074,"HFD-560 to Hyman Phelps & McNamara, P. C.",Other,LET-Letter,1998-07-29T04:00:00Z,1998,7,,,2008-05-30T22:53:09Z,,0,0,09000064805bb48f
FDA-1998-P-0086-0001,FDA,FDA-1998-P-0086,Letter from FDA/CFSAN to Amway Corporation - Nutrilite Division,Other,Letter(s),1998-07-23T04:00:00Z,1998,7,,,2015-12-04T21:20:47Z,,0,0,09000064805850e3
FDA-1998-D-0101-0001,FDA,FDA-1998-D-0101,FDA,Notice,NAD-Notice of Availability of Data,1998-07-20T04:00:00Z,1998,7,1998-07-20T04:00:00Z,1998-10-14T03:59:59Z,2008-05-16T21:23:23Z,,0,0,09000064805871c3
FDA-1997-N-0058-0002,FDA,FDA-1997-N-0058,FDA/CDER,Supporting & Related Material,REF-Reference (internal unless indicated),1998-07-15T04:00:00Z,1998,7,,,2008-05-16T22:01:12Z,,0,0,09000064805d0298
FDA-1994-N-0036-0001,FDA,FDA-1994-N-0036,FDA,Notice,NFR-Notice of Final Rule,1998-07-06T04:00:00Z,1998,7,1998-07-06T04:00:00Z,1998-07-31T03:59:59Z,2008-05-16T23:15:35Z,,0,0,09000064804fd6ba
FDA-1998-N-0106-0001,FDA,FDA-1998-N-0106,FDA,Notice,NIR-Notice of Interim Rule,1998-06-30T04:00:00Z,1998,6,1998-06-30T04:00:00Z,1998-09-09T03:59:59Z,2008-05-16T21:38:08Z,,0,0,0900006480587cc3
FDA-1998-N-0106-0003,FDA,FDA-1998-N-0106,References to NIR1,Supporting & Related Material,BKG-Background Material,1998-06-30T04:00:00Z,1998,6,,,2008-05-16T21:38:08Z,,0,0,0900006480587d5a
FDA-1998-N-0007-0001,FDA,FDA-1998-N-0007,Food Labeling: Health Claims; Omega-3 Fatty Acids and the Risk in Adults of Cardiovascular Disease,Rule,Interim Final Rule,1998-06-30T04:00:00Z,1998,6,1998-06-22T04:00:00Z,1998-09-09T03:59:59Z,2017-08-16T18:18:32Z,98–16459,0,0,0900006480558b4a
FDA-1998-N-0106-0005,FDA,FDA-1998-N-0106,References to NIR1,Supporting & Related Material,BKG-Background Material,1998-06-30T04:00:00Z,1998,6,,,2008-05-16T21:38:08Z,,0,0,0900006480587d69
FDA-1998-N-0007-0002,FDA,FDA-1998-N-0007,References to NIR,Supporting & Related Material,BKG-Background Material,1998-06-30T04:00:00Z,1998,6,,,2017-08-16T13:52:50Z,,0,0,0900006480558b8e
FDA-1998-N-0007-0004,FDA,FDA-1998-N-0007,References to NIR,Supporting & Related Material,BKG-Background Material,1998-06-30T04:00:00Z,1998,6,,,2008-05-16T21:28:36Z,,0,0,0900006480558bbf
FDA-1998-N-0106-0002,FDA,FDA-1998-N-0106,References to NIR1,Supporting & Related Material,BKG-Background Material,1998-06-30T04:00:00Z,1998,6,,,2008-05-16T21:38:08Z,,0,0,0900006480587d43
FDA-1998-N-0007-0003,FDA,FDA-1998-N-0007,References to NIR,Supporting & Related Material,BKG-Background Material,1998-06-30T04:00:00Z,1998,6,,,2008-05-16T21:28:36Z,,0,0,0900006480558bb7
FDA-1998-N-0106-0004,FDA,FDA-1998-N-0106,References to NIR1,Supporting & Related Material,BKG-Background Material,1998-06-30T04:00:00Z,1998,6,,,2008-05-16T21:38:08Z,,0,0,0900006480587d62
FDA-1998-N-0006-0001,FDA,FDA-1998-N-0006,Administrative Practices and Procedures; Internal Agency Review of Decisions; Companion Document to Direct Final Rule,Notice,General Notice,1998-06-25T04:00:00Z,1998,6,1998-06-25T04:00:00Z,1998-09-01T03:59:59Z,2025-02-25T18:16:51Z,98-15814,0,0,0900006480558a26
FDA-1998-N-0006-0002,FDA,FDA-1998-N-0006,Administrative Practices and Procedures; Internal Review of Agency Decisions,Notice,Notice of Final Rule,1998-06-25T04:00:00Z,1998,6,1998-06-25T04:00:00Z,1998-09-01T03:59:59Z,2025-02-25T19:05:13Z,98-,0,0,0900006480558a65
FDA-1998-D-0052-0001,FDA,FDA-1998-D-0052,FDA,Notice,NAD-Notice of Availability of Data,1998-06-23T04:00:00Z,1998,6,1998-06-23T04:00:00Z,1998-08-27T03:59:59Z,2008-05-16T21:23:07Z,,0,0,090000648056e961
FDA-1978-N-0021-0007,FDA,FDA-1978-N-0021,Notice of Proposed Rulemaking- Laxative Drug Products for Over-the-Counter Human Use; Proposed Amendment to the Tentative Final Monograph,Proposed Rule,Notice of Proposed Rulemaking (NPRM),1998-06-23T04:00:00Z,1998,6,1998-06-23T04:00:00Z,1998-09-18T03:59:59Z,2016-09-22T14:17:32Z,,0,0,090000648055d3ce
FDA-1998-D-0102-0001,FDA,FDA-1998-D-0102,FDA,Notice,NAD-Notice of Availability of Data,1998-06-12T04:00:00Z,1998,6,,,2008-05-16T21:23:24Z,,0,0,0900006480587328
FDA-1998-D-0102-0002,FDA,FDA-1998-D-0102,Guidance for Industry Notification of a Health Claim or Nutrient Content Claim Based on an Authoritative Statement of a Scientific Body,Other,Guidance,1998-06-12T04:00:00Z,1998,6,,,2024-11-07T21:53:55Z,,1,0,0900006480587376
FDA-1998-D-0052-0004,FDA,FDA-1998-D-0052,Guidance,Supporting & Related Material,GDL-Guidance,1998-06-11T04:00:00Z,1998,6,,,2008-05-16T21:23:07Z,,0,0,090000648056e98d
FDA-1980-N-0067-0003,FDA,FDA-1980-N-0067,Letter from FDA CDER to Nonprescription Drug Manufacturers Association,Other,Letter(s),1998-06-09T04:00:00Z,1998,6,,,2022-06-06T15:15:58Z,,0,0,09000064805bb049
FDA-1998-D-0098-0001,FDA,FDA-1998-D-0098,FDA,Notice,NAD-Notice of Availability of Data,1998-06-09T04:00:00Z,1998,6,1998-06-09T04:00:00Z,1998-09-10T03:59:59Z,2008-05-16T21:23:17Z,,0,0,0900006480586c2e
FDA-1998-D-0095-0002,FDA,FDA-1998-D-0095,Guidance,Supporting & Related Material,GDL-Guidance,1998-06-05T04:00:00Z,1998,6,,,2008-05-16T21:23:14Z,,0,0,0900006480586884
FDA-1998-D-0095-0001,FDA,FDA-1998-D-0095,FDA,Notice,NAD-Notice of Availability of Data,1998-06-05T04:00:00Z,1998,6,1998-06-05T04:00:00Z,1998-08-01T03:59:59Z,2008-05-16T21:23:14Z,,0,0,0900006480586845
FDA-1979-N-0028-0013,FDA,FDA-1979-N-0028,Permanent Listing of Color Additive Lakes; Additions to the Administrative Record; Reopening of Comment Period - Notice of Proposed Rule,Proposed Rule,Notice of Proposed Rulemaking (NPRM),1998-06-03T04:00:00Z,1998,6,1998-06-03T04:00:00Z,1998-07-07T03:59:59Z,2014-05-15T01:01:28Z,,0,0,090000648055399f
FDA-1997-P-0054-0001,FDA,FDA-1997-P-0054,"FDA/CDER Response to the Center for Positron Emission Tomography, State University of New York at Buffalo, Department of Nuclear Medicine, May 26, 1998 - Petition Approval",Other,PAV-Petition Approval,1998-06-01T04:00:00Z,1998,6,,,2013-08-11T04:24:37Z,,0,0,09000064805cfd12
FDA-1995-S-0039-0056,FDA,FDA-1995-S-0039,Report from FDA/CFSAN,Other,RPT-Report,1998-05-28T04:00:00Z,1998,5,2008-10-06T04:00:00Z,,2016-09-30T14:22:27Z,,0,0,090000648055c385
FDA-1996-P-0246-0019,FDA,FDA-1996-P-0246,Memorandum of Meeting Between FDA CFSAN Meeting With National Confectioners Association (NCA) and Chocolate Manufacturers Association (CMA) May 6 1998,Other,Memorandum,1998-05-22T04:00:00Z,1998,5,2014-02-20T05:00:00Z,,2014-02-20T14:21:04Z,,0,0,090000648050397e
FDA-1996-P-0309-0019,FDA,FDA-1996-P-0309,"Memorandum of Meeting Between FDA/CFSAN and Chocolate Manufacturers Association (CMA) and the National Confectioners Association (NCA) May 6, 1998",Other,Memorandum,1998-05-22T04:00:00Z,1998,5,2014-02-20T05:00:00Z,,2014-02-20T12:34:11Z,,0,0,0900006480504c8a
FDA-1997-D-0027-0002,FDA,FDA-1997-D-0027,FDA,Notice,NAD-Notice of Availability of Data,1998-05-20T04:00:00Z,1998,5,,,2008-05-16T21:59:18Z,,0,0,09000064805ca339
FDA-1998-N-0105-0001,FDA,FDA-1998-N-0105,FDA,Notice,N-Notice,1998-05-19T04:00:00Z,1998,5,,,2008-05-16T21:38:06Z,,0,0,0900006480587b38
FDA-1979-N-0028-0012,FDA,FDA-1979-N-0028,"Memorandum of Telephone Conversation Dated January 29, 1997",Other,Memorandum,1998-05-15T04:00:00Z,1998,5,,,2014-05-14T15:45:57Z,,0,0,090000648055399e
FDA-1979-N-0028-0010,FDA,FDA-1979-N-0028,"Memorandum of Telephone Conversation Dated December 23, 1996",Other,Memorandum,1998-05-15T04:00:00Z,1998,5,,,2014-05-14T15:40:40Z,,0,0,090000648055399c
FDA-1979-N-0028-0011,FDA,FDA-1979-N-0028,"Memorandum of Telephone Conversation Dated January 10, 1997",Other,Memorandum,1998-05-15T04:00:00Z,1998,5,,,2014-05-14T15:42:52Z,,0,0,090000648055399d
FDA-1986-V-0024-0001,FDA,FDA-1986-V-0024,Lasertainment Productions Int - Approval for Variance,Other,VRA-Approval for Variance,1998-05-06T04:00:00Z,1998,5,,,2013-08-11T04:14:18Z,,0,0,090000648050df6a
FDA-1998-N-0107-0001,FDA,FDA-1998-N-0107,Medical Devices; 30-Day Notices and 135-Day PMA Supplement Review,Notice,Notice of Final Rule,1998-05-05T04:00:00Z,1998,5,1998-05-05T04:00:00Z,1998-07-14T03:59:59Z,2026-02-07T03:28:03Z,98-11086,0,0,0900006480587e9f
FDA-1998-N-0071-0001,FDA,FDA-1998-N-0071,Regulations on Statements made for Dietary Supplements Concerning the Effects of the Products on the Structure or Function of the Body,Proposed Rule,NPR-Notice of Proposed Rule-Making,1998-05-01T04:00:00Z,1998,5,1998-05-01T04:00:00Z,1998-08-28T03:59:59Z,2008-07-23T23:34:30Z,,0,0,0900006480571e04
FDA-1995-S-0039-0065,FDA,FDA-1995-S-0039,Report from FDA/CFSAN,Other,RPT-Report,1998-04-30T04:00:00Z,1998,4,2008-10-06T04:00:00Z,,2016-09-30T14:22:30Z,,0,0,0900006480738cc4
FDA-1995-C-0050-0001,FDA,FDA-1995-C-0050,Listing of Color Additives for Coloring Sutures;  D&C Violet No. 2,Rule,Final Rule,1998-04-23T04:00:00Z,1998,4,1998-04-23T04:00:00Z,1998-05-27T03:59:59Z,2017-06-13T18:06:37Z,98 10779,0,0,0900006480561d4f
FDA-1975-N-0013-0001,FDA,FDA-1975-N-0013,Status of Certain Additional Over-the-Counter Drug Category II and III Active Ingredients,Notice,Notice of Final Rule,1998-04-22T04:00:00Z,1998,4,,,2017-11-16T02:02:43Z,98–10578,0,0,09000064805c1d3c
FDA-1997-N-0066-0001,FDA,FDA-1997-N-0066,Notice of Proposed Rulemaking re Revisions to the General Safety Requirements for Biological Products; Companion Document to Direct Final Rule,Proposed Rule,Notice of Proposed Rulemaking (NPRM),1998-04-21T04:00:00Z,1998,4,1998-04-21T04:00:00Z,2008-05-16T03:59:59Z,2015-12-07T18:50:44Z,,0,0,09000064805d04c7